Lysogenic HSV Virus

1

Review clinical trials related to Lysogenic HSV Virus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus

Evaluation of the safety and tolerability of immune-targeted therapy combined with neoadjuvant therapy with lysogenic HSV virus for patients with surgically resectable squamous carcinoma of the head and neck.

Participants needed: 21
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: West China HospitalUpdated: Dec 19, 2024Locations: 1
Eligibility criteria

Age ≥18 and ≤70 years old, regardless of gender; [+8]

Lymph node staging of N0 or Nx status; [+18]